We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

48 hedge funds and large institutions have $13.8M invested in vTv Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more capital invested

Capital invested by funds: $4.94M → $13.8M (+$8.87M)

144% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 9

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

9% more funds holding

Funds holding: 44 → 48 (+4)

0.08% more ownership

Funds ownership: 0.12% → 0.21% (+0.08%)

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$1.73M
2
Two Sigma Investments
Two Sigma Investments
New York
+$927K
3
Citadel Advisors
Citadel Advisors
Florida
+$442K
4
Marshall Wace
Marshall Wace
United Kingdom
+$435K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$372K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$140K
2
VF
Virtu Financial
New York
-$70K
3
Squarepoint
Squarepoint
New York
-$61K
4
N
Natixis
France
-$42K
5
OQS
Occudo Quantitative Strategies
Florida
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$60K – – –
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$57K +$14.1K +143 +39%
Bank of America
28
Bank of America
North Carolina
$48K +$35.7K +363 +595%
GPFA
29
Game Plan Financial Advisors
Ohio
$41K +$36.8K +375 New
Millennium Management
30
Millennium Management
New York
$36K +$30.9K +315 New
XT
31
XTX Topco
Cayman Islands
$31K +$27.4K +279 New
Wells Fargo
32
Wells Fargo
California
$30K -$28K -285 -52%
TRCT
33
Tower Research Capital (TRC)
New York
$30K +$13.4K +136 +102%
Barclays
34
Barclays
United Kingdom
$28K +$15.6K +159 +179%
Deutsche Bank
35
Deutsche Bank
Germany
$18K -$1.67K -17 -10%
UBS Group
36
UBS Group
Switzerland
$11K -$13.6K -138 -58%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$9K +$4.03K +41 +89%
Morgan Stanley
38
Morgan Stanley
New York
$6K -$19.5K -198 -78%
Osaic Holdings
39
Osaic Holdings
Arizona
$6K – – –
Legal & General Group
40
Legal & General Group
United Kingdom
$5K – – –
PA
41
Parallel Advisors
California
$4K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$4K +$1.47K +15 +63%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$3.38K -$295 -3 -9%
Citigroup
44
Citigroup
New York
$2K -$2.55K -26 -57%
AIP
45
Ameritas Investment Partners
Nebraska
$2K – – –
FIA
46
FNY Investment Advisers
New York
$1K +$1.47K +15 New
AIG
47
American International Group
New York
$19 +$1.28K +13 +8%
Renaissance Technologies
48
Renaissance Technologies
New York
– -$140K -1,888 Closed
VF
49
Virtu Financial
New York
– -$70K -942 Closed
Squarepoint
50
Squarepoint
New York
– -$61K -821 Closed
1
2
3

VTVT Hedge Fund Activity: Q1 2021 in Review

48 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q1 2021, worth a combined $13.8M — up 180% from $4.94M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VTVT positions and 7 closed out — a net gain of 5 holders — while 22 added to existing stakes and 9 trimmed.

The largest buyer was Nuveen, adding an estimated $1.73M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $140K sold.

  • 48 institutional investors held vTv Therapeutics (VTVT) as of Q1 2021, up from 44 in Q4 2020.
  • Funds reported $13.8M of vTv Therapeutics stock for Q1 2021, up 180% quarter-over-quarter.
  • 12 funds opened new vTv Therapeutics positions in Q1 2021 and 7 closed out, a net change of +5 holders.
  • The largest vTv Therapeutics buyer in Q1 2021 was Nuveen, an estimated $1.73M added.
  • The largest vTv Therapeutics seller in Q1 2021 was Renaissance Technologies, an estimated $140K sold.

Based on aggregated 13F filings for Q1 2021.